SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Wadelius Mia) ;lar1:(liu)"

Sökning: WFRF:(Wadelius Mia) > Linköpings universitet

  • Resultat 1-6 av 6
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Franks, P. W., et al. (författare)
  • Technological readiness and implementation of genomic-driven precision medicine for complex diseases
  • 2021
  • Ingår i: Journal of Internal Medicine. - : Wiley. - 0954-6820 .- 1365-2796. ; 290:3, s. 602-620
  • Forskningsöversikt (refereegranskat)abstract
    • The fields of human genetics and genomics have generated considerable knowledge about the mechanistic basis of many diseases. Genomic approaches to diagnosis, prognostication, prevention and treatment - genomic-driven precision medicine (GDPM) - may help optimize medical practice. Here, we provide a comprehensive review of GDPM of complex diseases across major medical specialties. We focus on technological readiness: how rapidly a test can be implemented into health care. Although these areas of medicine are diverse, key similarities exist across almost all areas. Many medical areas have, within their standards of care, at least one GDPM test for a genetic variant of strong effect that aids the identification/diagnosis of a more homogeneous subset within a larger disease group or identifies a subset with different therapeutic requirements. However, for almost all complex diseases, the majority of patients do not carry established single-gene mutations with large effects. Thus, research is underway that seeks to determine the polygenic basis of many complex diseases. Nevertheless, most complex diseases are caused by the interplay of genetic, behavioural and environmental risk factors, which will likely necessitate models for prediction and diagnosis that incorporate genetic and non-genetic data.
  •  
3.
  • Josefsson, Ann, et al. (författare)
  • CYP2D6 genotypes and depressive symptoms during late pregnancy and postpartum
  • 2004
  • Ingår i: Nordic Journal of Psychiatry. - : Informa UK Limited. - 0803-9488 .- 1502-4725. ; 58:1, s. 61-4
  • Tidskriftsartikel (refereegranskat)abstract
    • The aim of this exploratory was to investigate the theory of a relation between cytochrome P450 2D6 (CYP2D6) genotype and depressive symptoms in late pregnancy and/or postpartum. We studied 145 women with depressive symptoms. CYP2D6 genotype was analysed in leukocyte DNA by polymerase chain reaction (PCR). There were no significant differences in CYP2D6 genotypes between the groups of women being depressed during and/or after pregnancy. The frequencies of CYP2D6 genotypes did not differ from other European studies. This study cannot confirm that depressive symptoms in late pregnancy and postpartum are connected with CYP2D6 genotype. It is, however, noteworthy that the frequency of ultrarapid metabolizers was higher than in a general Caucasian population. This warrants further exploration in a greater study sample, but should also be investigated in a general population with major depression.
  •  
4.
  • Kharazmi, Mohammad, et al. (författare)
  • A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture
  • 2019
  • Ingår i: Calcified Tissue International. - : SPRINGER. - 0171-967X .- 1432-0827. ; 105:1, s. 51-67
  • Tidskriftsartikel (refereegranskat)abstract
    • Atypical femoral fracture is a well-documented adverse reaction to bisphosphonates. It is strongly related to duration of bisphosphonate use, and the risk declines rapidly after drug withdrawal. The mechanism behind bisphosphonate-associated atypical femoral fracture is unclear, but a genetic predisposition has been suggested. With the aim to identify common genetic variants that could be used for preemptive genetic testing, we performed a genome-wide association study. Cases were recruited mainly through reports of adverse drug reactions sent to the Swedish Medical Products Agency on a nation-wide basis. We compared atypical femoral fracture cases (n=51) with population-based controls (n=4891), and to reduce the possibility of confounding by indication, we also compared with bisphosphonate-treated controls without a current diagnosis of cancer (n=324). The total number of single-nucleotide polymorphisms after imputation was 7,585,874. A genome-wide significance threshold of p<5x10(-8) was used to correct for multiple testing. In addition, we performed candidate gene analyses for a panel of 29 genes previously implicated in atypical femoral fractures (significance threshold of p<5.7x10(-6)). Compared with population controls, bisphosphonate-associated atypical femoral fracture was associated with four isolated, uncommon single-nucleotide polymorphisms. When cases were compared with bisphosphonate-treated controls, no statistically significant genome-wide association remained. We conclude that the detected associations were either false positives or related to the underlying disease, i.e., treatment indication. Furthermore, there was no significant association with single-nucleotide polymorphisms in the 29 candidate genes. In conclusion, this study found no evidence of a common genetic predisposition for bisphosphonate-associated atypical femoral fracture. Further studies of larger sample size to identify possible weakly associated genetic traits, as well as whole exome or whole-genome sequencing studies to identify possible rare genetic variation conferring a risk are warranted.
  •  
5.
  • Verhoef, Talitha I, et al. (författare)
  • Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs
  • 2012
  • Ingår i: Pharmacogenomics (London). - : Future Medicine. - 1462-2416 .- 1744-8042. ; 13:12, s. 1405-1417
  • Forskningsöversikt (refereegranskat)abstract
    • Genotyping patients for CYP2C9 and VKORC1 polymorphisms can improve the accuracy of dosing during the initiation of anticoagulation with vitamin K antagonists (coumarin derivatives). The anticipated degree of improvement in the safety of anticoagulation with coumarins through genotyping may vary depending on the quality of patient care, which varies both with and among countries. The management and the cost of anticoagulant care can therefore influence the cost effectiveness of genotyping within any given country. In this article, we provide an overview of the cost effectiveness of pharmacogenetics-guided dosing of coumarin derivatives. We describe the organization of anticoagulant care in the UK, Sweden, The Netherlands, Greece, Germany and Austria, where a genotype-guided dosing algorithm is currently being investigated as part of the EU-PACT trial. We also explore the costs of anticoagulant care for the treatment of atrial fibrillation in these countries.
  •  
6.
  • Ås, Joel, et al. (författare)
  • Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs
  • 2024
  • Ingår i: PLOS ONE. - : PUBLIC LIBRARY SCIENCE. - 1932-6203. ; 19:2
  • Tidskriftsartikel (refereegranskat)abstract
    • A genetic predisposition to central nervous system (CNS) toxicity induced by antimicrobial drugs (antibiotics, antivirals, antifungals, and antiparasitic drugs) has been suspected. Whole genome sequencing of 66 cases and 833 controls was performed to investigate whether antimicrobial drug-induced CNS toxicity was associated with genetic variation. The primary objective was to test whether antimicrobial-induced CNS toxicity was associated with seventeen efflux transporters at the blood-brain barrier. In this study, variants or structural elements in efflux transporters were not significantly associated with CNS toxicity. Secondary objectives were to test whether antimicrobial-induced CNS toxicity was associated with genes over the whole genome, with HLA, or with structural genetic variation. Uncommon variants in and close to three genes were significantly associated with CNS toxicity according to a sequence kernel association test combined with an optimal unified test (SKAT-O). These genes were LCP1 (q = 0.013), RETSAT (q = 0.013) and SFMBT2 (q = 0.035). Two variants were driving the LCP1 association: rs6561297 (p = 1.15x10-6, OR: 4.60 [95% CI: 2.51-8.46]) and the regulatory variant rs10492451 (p = 1.15x10-6, OR: 4.60 [95% CI: 2.51-8.46]). No common genetic variant, HLA-type or structural variation was associated with CNS toxicity. In conclusion, CNS toxicity due to antimicrobial drugs was associated with uncommon variants in LCP1, RETSAT and SFMBT2.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-6 av 6
Typ av publikation
tidskriftsartikel (4)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (6)
Författare/redaktör
Wadelius, Mia (6)
Rosenquist, R. (2)
Jacobsson, Bo, 1960 (2)
Nordmark, Gunnel (2)
Johansson, Åsa (2)
Levin, Lars-Åke (2)
visa fler...
Repsilber, Dirk, 197 ... (2)
Engstrand, L (1)
KLARESKOG, L (1)
Söderkvist, Peter (1)
Almqvist, C (1)
Kockum, I. (1)
Cavelier, Lucia (1)
Bergen, S. E. (1)
Berg, Göran (1)
Hagstrom, H (1)
Fioretos, Thoas (1)
Hall, P (1)
Czene, K (1)
Josefsson, Ann (1)
Jern, Christina, 196 ... (1)
Melen, E (1)
Stenmark, Bianca, 19 ... (1)
Johansson, Anna (1)
Wedell, A (1)
Halfvarson, Jonas, 1 ... (1)
Ohlsson, Claes, 1965 (1)
Benson, Mikael (1)
Helenius, Gisela, 19 ... (1)
Green, Henrik (1)
Rönnblom, Lars (1)
Catrina, A (1)
Sundström, Johan, Pr ... (1)
Sydsjö, Gunilla (1)
Larsson, Pär (1)
Fall, Tove, 1979- (1)
Orešič, Matej, 1967- (1)
Pirmohamed, Munir (1)
Daly, Ann K. (1)
Orho-Melander, M. (1)
Wirta, Valtteri (1)
Melhus, Håkan (1)
Palmqvist, Richard (1)
Dahl, Marja-Liisa (1)
Johansson, Maria (1)
Lindstrand, A (1)
Gyllensten, Ulf (1)
Franks, P.W. (1)
Palmqvist, Lars, 196 ... (1)
Michaëlsson, Karl, 1 ... (1)
visa färre...
Lärosäte
Uppsala universitet (6)
Umeå universitet (3)
Göteborgs universitet (2)
Örebro universitet (2)
Lunds universitet (2)
visa fler...
Karolinska Institutet (2)
Kungliga Tekniska Högskolan (1)
visa färre...
Språk
Engelska (6)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (5)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy